At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Cortical Changes in Total and Partial Vestibular Dysfunction, As Measured by EEG
Study Supports Expanded Candidacy for Pediatric Cochlear Implantation For children less than two years of age, current Food and Drug Administration (FDA) candidacy criteria for…
Academy Submits Comments on MPFS Proposed Rule CY 2027
On behalf of the membership, the American Academy of Audiology has submitted comments on the Centers for Medicare and Medicaid Services’ (CMS) Calendar Year (CY)…
Where do U.S. Adults Obtain Their Usual Healthcare?
While we know that primary care providers can be a source of referrals for audiologic care, have you wondered how many individuals have a regular…



